Table 1.
Characteristics and clinical course of published cases of liposarcoma of the spermatic cord
| No. | age (y) | Duration | Location | Size (cm) | Treatment | Pathology | Follow –up | Outcome |
|---|---|---|---|---|---|---|---|---|
| 12 |
53 |
NA |
L.s |
6 × 7 |
RO |
WDL |
3 yr |
Recurrence |
| 22 |
70 |
6 mo |
R.s |
13 × 7 × 3.5 |
RO |
WDL |
6 yr |
Recurrence |
| 32 |
34 |
NA |
L.s |
1.5 × 2.5 |
RO |
WDL |
4 yr |
NRD |
| 42 |
56 |
10 yr |
L.s |
8.5 × 7.5 × 4.5 |
RO+rad |
PDL, WDL |
18 mo |
NRD |
| 52 |
53 |
NA |
L.s |
NA |
RO |
DL |
18 mo |
NRD |
| 62 |
71 |
2 yr |
L.s |
NA |
RO |
WDL |
3 mo |
NRD |
| 75 |
59 |
5 yr |
L.s |
50 × 27.5 × 15 (10.9 kg) |
RO |
WDL |
3 yr |
NRD |
| 86 |
60 |
7 mo |
R.s; RP |
14 × 3.8 × 3.5; 24 × 10 × 8 |
TR; RO |
WDL (St) |
4 yr |
NRD |
| 97 |
71 |
5 mo |
L.s |
9.5 × 5.5 |
RO |
DL |
4 mo |
NRD |
| 108 |
52 |
3 mo |
L.s |
0.4 |
TR |
WDL |
3 yr |
NRD |
| 1110 |
69 |
1 yr |
L.s |
16 × 6 × 5 |
RO+rad |
WDL (St) |
NA |
NA |
| 1211 |
53 |
6 mo |
R.s |
7.5 × 4.5 × 4 |
RO |
WDL (St) |
NA |
NA |
| 1312 |
76 |
1 wk |
L.s |
6 × 5 × 3 |
TR |
WDML |
NA |
NA |
| 1413 |
24 |
6 mo |
R.s |
5 |
TR |
WDML |
1 yr |
NRD |
| 1514 |
79 |
3 mo |
L.s |
12 × 6 (730 g) |
RO |
ML |
1 yr |
NRD |
| 1615 |
60 |
4 yr |
R.s |
15 × 20 (760 g) |
RO |
WDML |
NA |
NA |
| 1716 |
44 |
1 yr |
L.s |
20 × 15 |
RO |
WDL (St) |
1 yr |
NRD |
| 1817 |
60 |
6 yr |
R.s |
5 × 4 |
RO |
WDL |
3 yr |
NRD |
| 1918 |
75 |
18 mo |
L.s |
20 × 15 |
RO |
ML |
NA |
NA |
| 2018 |
54 |
NA |
L.s |
20 × 20 |
RO |
PL |
NA |
NA |
| 2119 |
73 |
6 mo |
R.s |
15 × 10 × 14 |
RO |
WDL |
8 yr |
NRD |
| 2219 |
47 |
NA |
R.s |
3 |
RO |
WDL |
20 mo |
NRD |
| 2320 |
73 |
1 yr |
R.s |
17 × 13 × 4 |
RO rad |
DL |
2 yr |
NRD |
| 2420 |
68 |
1mo |
R.s |
8 × 6 × 6 |
RO |
WDL (St) |
6 mo |
NRD |
| 2522. |
73 |
NA |
L.s; RP |
4.1 × 3.5 × 3; 3.3 × 3.3 × 2 |
RO; TR |
NA |
6 mo |
NRD |
| 2623 |
40 |
NA |
R.s |
50 × 50 × 35 (42 kg) |
TR |
WDL (St) |
12 mo |
NRD |
| 2724 |
65 |
NA |
R.s |
34 × 22 × 17 (5,786 g) |
RO |
DL |
48 mo |
NRD |
| 2825 |
75 |
NA |
NA |
14 × 8 × 9 |
RO |
PL |
NA |
NA |
| 2926 |
47 |
6 mo |
L.s |
4 × 3 × 3; 4 × 2 × 2 |
RO |
WDML; A |
30 mo |
NRD |
| 3027 |
73 |
18 mo |
L.s |
10 × 8 × 7 |
RO |
ML |
NA |
NA |
| 3129 |
65 |
1 yr |
R.s |
14 × 8 × 5 |
RO |
WDML |
3 mo |
NRD |
| 3230 |
64 |
4 yr |
L.s |
26 × 15 × 7 (785 g) |
RO |
WDL |
3 mo |
NRD |
| 3332 |
57 |
1.5 yr |
L.s |
11 × 7.5 × 5 |
RO+rad |
DL |
10 yr |
NRD |
| 3432 |
60 |
NA |
R.s |
3 × 1.8 × 1.5 |
RO |
WDL (St) |
1 yr |
Recurrence |
| 3533 |
57 |
1 yr |
L.s |
9 × 6.5 |
RO+rad |
DL |
NA |
NA |
| 3634 |
66 |
3 mo |
R.s |
5 × 10 |
RO |
PDML |
6 mo |
Metastases |
| 3735 |
60 |
1 yr |
L.s |
10 × 10 × 5 |
RO |
WDL (St) |
3 yr |
Recurrence |
| 3836 |
48 |
2 yr |
R.s |
NA |
RO |
WDL |
3 yr |
NRD |
| Our case | 53 | 2 yr | L.s | 6 × 5 × 3 | RO | WDML | 18 mo | NRD |
Abbreviations: A, angiolipoma; DL, dedifferentiated liposarcoma; L.s, left side; ML, myxoid liposarcoma; NA, not available; NRD, no recurrence of disease; PDL, poorly-differentiated liposarcoma; PDML, poorly-differentiated myxoid liposarcoma; PL, pleomorphic liposarcoma; rad, radiotherapy; R.s, right side; RO, radical orchiectomy; RP, retroperitoneum; St, sclerosing type; TR, tumor resection; WDL, well-differentiated liposarcoma; WDML, well-differentiated myxoid liposarcoma.